On ECHEMI
Home > Drugs > cholecystitis
cholecystitis
Cholecystitis is an inflammatory disease of the gallbladder caused by bacterial infection or chemical stimulation (change in bile composition). It is a common disease of the gallbladder. Its incidence rate is second only to appendicitis in abdominal surgery. This disease is more common in middle-aged people aged 35 to 55 years old. Women are more likely to get it than men, especially obese women who have had multiple pregnancies.
Related Drugs
Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Anti-inflammatory and choleretic tablets
Manufacturer:

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Anti-inflammatory and choleretic tablets
Manufacturer:

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

Anti-inflammatory and choleretic tablets
Manufacturer:

Dalian Zhenao Pharmaceutical Co., Ltd.

Cefixime Capsules
Indication: It is effective for the following infections caused by cefixime-sensitive bacteria among Streptococcus (except Enterococcus), Pneumococcus, Neisseria gonorrhoeae, Branhamella catarrhalis, Escherichia coli, Klebsiella, Serratia, Proteus, and Haemophilus influenzae.
Manufacturer:

Shanghai Haihong Industry (Group) Chaohu Jinchen Pharmaceutical Co., Ltd.

Cefixime Capsules
Indication: This product is suitable for the following bacterial infectious diseases caused by Streptococcus (except enterococci), pneumococcus, gonococcus, Branhamella catarrhalis, Escherichia coli, Klebsiella, Serratia, Proteus and influenza bacilli: 1. Bronchitis, bronchiectasis (when infected), secondary infection of chronic respiratory system infections, pneumonia; 2. Pyelonephritis, cystitis, gonococcal urethritis; 3. Cholecystitis, cholangitis; 4. Scarlet fever; 5. Otitis media, sinusitis.
Manufacturer:

Jinri Pharmaceutical (China) Co., Ltd.

Cefixime Capsules
Indication: Broad-spectrum antibiotic. Effective against infections caused by Streptococcus, Pneumococcus, Gonorrhea, Borrelia, Escherichia coli, Klebsiella, Serratia, Proteus, and Haemophilus influenzae. Mainly used to treat bronchitis, bronchiectasis and infection, secondary infection of chronic respiratory diseases, pneumonia, pyelonephritis, cystitis, gonococcal urethritis, cholecystitis, cholangitis,
Manufacturer:

Sinopharm ZHIJUN(Shenzhen)PHARMACEUTICAL Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.